| Ms Marilee Grace Tuifua, LCSW | |
|
11113 S Mesa Vista Ct, South Jordan, UT 84095-8169 | |
| (801) 694-2806 | |
| Not Available |
| Full Name | Ms Marilee Grace Tuifua |
|---|---|
| Gender | Female |
| Speciality | Counselor |
| Location | 11113 S Mesa Vista Ct, South Jordan, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083166292 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | 4780264-3501 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Marilee Grace Tuifua, LCSW 11113 S. Mesa Vista Court, South Jordan, UT 84095 Ph: (801) 694-2806 | Ms Marilee Grace Tuifua, LCSW 11113 S Mesa Vista Ct, South Jordan, UT 84095-8169 Ph: (801) 694-2806 |
News Archive
Researchers from the USA discuss the development and validation of CRISPR-Cas12-based COVID-19 variant DETECTR® assay for the detection of SARS-CoV-2.
Takeda Pharmaceutical Company Limited ("Takeda") and Pfizer Inc. ("Pfizer") announced that they have entered into an agreement under which Pfizer in China will co-promote Takeda's Actos® (pioglitazone HCl) with Tianjin Takeda Pharmaceuticals in China.
A new study published in the journal Molecular Therapy reveals that HIV DNA in the genome of living animals can be removed to eliminate further infection. While a permanent cure for infection caused by HIV remains a challenge due to the ability of the virus to hide away in latent reservoirs. The study team comprising Wenhui Hu, Kamel Khalili, Laura H. Carnell, and Won-Bin Young carried out an experiment on three different animal models.
3D Signatures Inc. is pleased to announce that a preliminary third-party analysis of the trial data for Telo-HL, 3DS' test in development for Hodgkin's lymphoma (HL), shows that the Company's TeloViewTM platform is able to distinguish, with a high degree of statistical significance, multiple differences between a patient group that responds to standard ABVD chemotherapy, and a group that relapses or is refractory to treatment within the first 12 months.
› Verified 1 days ago
Patricia Hayner, Counselor Medicare: Not Enrolled in Medicare Practice Location: 10298 S Otter Trail Dr, South Jordan, UT 84009 Phone: 951-541-3043 | |
Stephanie Church Kelley, ACMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1108 W South Jordan Pkwy Ste B, South Jordan, UT 84095 Phone: 385-215-9084 | |
Caitlin Lilah Rollins, Counselor Medicare: Medicare Enrolled Practice Location: 1108 W South Jordan Pkwy Ste B, South Jordan, UT 84095 Phone: 385-215-9084 | |
Jennifer Hong, ACMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1108 W South Jordan Pkwy Ste B, South Jordan, UT 84095 Phone: 385-215-9084 | |
Eric Bylund, Counselor Medicare: Not Enrolled in Medicare Practice Location: 11260 S River Heights Dr., South Jordan, UT 84095 Phone: 801-298-2000 | |
Virginia Carolyn Williams Anderson, ACMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1108 W South Jordan Pkwy Ste B, South Jordan, UT 84095 Phone: 385-215-9084 | |
Trudy Bond, L.P.C. Counselor Medicare: Not Enrolled in Medicare Practice Location: 1258 W South Jordan Pkwy, South Jordan, UT 84095 Phone: 801-599-8954 |